Main menu button

News

Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
31 May 2024
Equity research Abera Bioscience: Bird flu cases put vaccine companies in the spotlight
Equity Research Abera Bioscience
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
30 May 2024
Equity Research ALM Equity, Q1 2024: Improved gross profit despite lower sales
Equity Research ALM Equity
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
23 May 2024
Equity research Abera Bioscience Q1 2024: Increased focus on new projects
Equity Research Abera Bioscience
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
23 May 2024
Equity research Zinzino, Q1 2024: Solid growth outlook confirmed
Equity Research Zinzino
Equity research Zinzino, Q1 2024: Growth and some scalability
22 May 2024
Equity research Zinzino, Q1 2024: Growth and some scalability
Equity Research Zinzino
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
22 May 2024
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
Equity Research Carlsquare
Equity Research GIAB, Q1 2024: Third savings programme to break even
21 May 2024
Equity Research GIAB, Q1 2024: Third savings programme to break even
Equity Research
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
20 May 2024
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
Equity Research
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
20 May 2024
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
Equity Research Viva Wine Group
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
17 May 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research Nosa Plugs
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
16 May 2024
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
Equity Research
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
16 May 2024
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
Equity Research
Equity research Viva Wine Group, Q1 2024: Profitability above our expectations despite soft top-line
16 May 2024
Equity research Viva Wine Group, Q1 2024: Profitability above our expectations despite soft top-line
Equity Research Viva Wine Group
Equity research HANZA Q1, 2024: Temporarily in a lower orbit
15 May 2024
Equity research HANZA Q1, 2024: Temporarily in a lower orbit
Equity Research Hanza
Carlsquare weekly market letter: Interest rates at a crossroads - will affect the whole market
15 May 2024
Carlsquare weekly market letter: Interest rates at a crossroads - will affect the whole market
Equity Research Carlsquare
Equity Research InCoax, Q1 2024: Strong start to 2024
10 May 2024
Equity Research InCoax, Q1 2024: Strong start to 2024
Equity Research InCoax
Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs
08 May 2024
Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs
Equity Research Svenska Aerogel
Carlsquare weekly market letter: Sell in May and stay away?
08 May 2024
Carlsquare weekly market letter: Sell in May and stay away?
Equity Research Carlsquare
First Impression InCoax Q1 2024: Much better sales and results than expected
07 May 2024
First Impression InCoax Q1 2024: Much better sales and results than expected
Equity Research InCoax
Equity research HANZA: First impression Q1 2024
07 May 2024
Equity research HANZA: First impression Q1 2024
Equity Research Hanza